 |
|
|
| |
Continued Efficacy and Safety Through 4 Years of Tenofovir Disoproxil Fumarate (TDF) Treatment in HBeAg-Negative Patients with Chronic Hepatitis B (Study 102)
|
| |
| |
Reported by Jules Levin
AASLD Oct 31 2010 Boston
P Marcellin1, M Buti2, Z Krastev3, S Gurel4, A M Di Bisceglie5, J A Odin6, G M Dusheiko7, E J Heathcote8, K Borroto-Esoda9, D H Coombs9, E Mondou9, J Anderson9
1Hopital Beaujon, University of Paris, Clichy, France; 2Servicio de Medicina Interna Hepatologia, Hospital General Universitari Vall d'Hebron and Ciberehd, Barcelona, Spain;
3University Hospital "St. Ivan Rilsky", Sofi a, Bulgaria; 4University of Uludag, Bursa, Turkey; 5Saint Louis University School Of Medicine, St. Louis, MO, USA;
6Mount Sinai School of Medicine, New York , NY, USA; 7Royal Free Hospital , London, UK; 8University of Toronto, Toronto, ON, Canada; 9Gilead Sciences, Durham, NC, USA.
|
| |
|
|
|
|
|
